Powered By
23 items
2026-11-18
Nomura Micro Science Co., Ltd. reported earnings results for the half year ended September 30, 2026. For the half year, the company reported sales was JPY 24,132 million. Net loss was JPY 226 million. Basic loss per share from continuing operations was JPY 5.89.
2026-11-16
Nomura Micro Science Co., Ltd. revised consolidated earnings guidance for the six months ending September 30, 2026. For the six months ending September 30, 2026, the company now expects sales revenue of JPY 24,180 million, operating profit of JPY 1,132 million, negative operating income to be JPY 141 million, net loss attributable to parent company shareholders of JPY 226 million, and net loss per share of JPY 5.88, compared to the previous forecast of sales revenue of JPY 24,180 million, operating profit of JPY 1,132 million, negative operating income to be JPY 141 million, net loss attributable to parent company shareholders of JPY 91 million, and net loss per share of JPY 2.37. For the second quarter (interim period), consolidated results are expected to include an income tax adjustment of JPY 135 million due to differences in tax rates and accounting treatments with overseas subsidiaries. Regarding the full-year consolidated earnings forecast, performance is expected to progress in line with the previous forecast. However, if the company determine that a revision to the earnings forecast is necessary in response to future developments, the company will promptly disclose it.
2026-11-13
Nomura Micro Science Co., Ltd., H1 2027 Earnings Call, Nov 18, 2026
2026-10-28
Nomura Micro Science Co., Ltd. revised consolidated earnings guidance for the six months ending September 30, 2026 and full fiscal year ending March 31, 2027. For the six months ending September 30, 2026, the company now expects sales revenue of JPY 24,180 million, operating profit of JPY 1,132 million, net loss attributable to parent company shareholders of JPY 91 million, and net loss per share of JPY 2.37, compared to the previous forecast of sales revenue of JPY 34,500 million, operating profit of JPY 3,600 million, net income attributable to parent company shareholders of JPY 1,961 million, and net income per share of JPY 51.22. Reasons for the revision: For the period, consolidated results are expected to show a decline in sales revenue, primarily because the timing of orders for large water treatment systems projects in the United States, which had been expected to be received in the first half, is now expected to shift to the second half. In addition, profitability is expected to fall below the beginning of period forecast due to factors including increased costs for large water treatment systems projects already ordered in South Korea. For the full year ending March 31, 2027, the company now expects sales revenue of JPY 97,000 million, operating profit of JPY 16,000 million, net income attributable to parent company shareholders of JPY 10,360 million, and net income per share of JPY 269.70, compared to the previous forecast of sales revenue of JPY 97,000 million, operating profit of JPY 16,000 million, net income attributable to parent company shareholders of JPY 11,100 million, and net income per share of JPY 289.90. Reasons for the revision: For the full-year consolidated earnings forecast, while inquiries in each region remain strong and progress-based sales for large water treatment systems projects in the United States are expected to be realized in the second half, the forecasts for sales revenue and operating profit remain unchanged from the beginning of period estimates. However, following a review of interest paid on borrowings and other factors, operating income and net income attributable to Parent company shareholders are expected to fall below the initial forecasts. Should the company determine that revisions to the earnings forecast are necessary depending on future developments, the company will promptly disclose them.
2026-08-12
Nomura Micro Science Co., Ltd. provided consolidated earnings guidance for the six month ending September 30, 2026 and fiscal year ending March 31, 2027. For the six month, the company expected net sales of JPY 34,500 million, operating profit of JPY 3,600 million, profit attributable to owners of parent of JPY 1,961 million and basic earnings per share of JPY 51.11. For the year, the company expected net sales of JPY 97,000 million, operating profit of JPY 16,000 million, profit attributable to owners of parent of JPY 11,100 million and basic earnings per share of JPY 289.21.
2026-07-24
Nomura Micro Science Co., Ltd., ¥ 30.0, Cash Dividend, Sep-29-2026
2026-07-15
Nomura Micro Science Co., Ltd., Board Meeting, Jul 15, 2026. Agenda: To consider and approve Regarding Issuance of Stock Options to our executive officers.
2026-06-24
Nomura Micro Science Co., Ltd. had informed that at the director meeting held on June 24, 2026, the company resolved to change the repayment date of the loan as follows regarding the 'Notice Regarding Changes to the Lending and Repayment Dates of Funds' dated February 13, 2026. In light of the cash flow situation of the group, the company will change the loan repayment date for the working capital of the large water treatment systems project secured by Nomura Micro Science USA Ltd. Co. Before change: Lender - Resona Bank, Limited, MUFG Bank, Ltd., Sumitomo Mitsui Banking Corporation; Borrowings amount - USD 200 million (maximum); Repayment due date - July 10, 2026; Interest rate - Benchmark interest rate+spread; Repayment method - Lump-sum repayment at maturity. After revision: Lender - Same; Borrowings amount - Same; Repayment due date - December 30, 2026; Interest rate - Same; Repayment method - Same. Before change: Lender - Resona Bank, Limited, MUFG Bank, Ltd., Sumitomo Mitsui Banking Corporation; Borrowings amount - USD 135 million; Repayment due date - July 10, 2026; Interest rate - Benchmark interest rate+spread; Repayment method - Lump-sum repayment at maturity. After revision: Lender - Same; Borrowings amount - Same; Repayment due date - December 30, 2026; Interest rate - Same; Repayment method - Same. The impact of this borrowing on the performance for Fiscal Year 2026 is minor.
2026-06-24
Nomura Micro Science Co., Ltd., Board Meeting, Jun 24, 2026. Agenda: To consider and approve Regarding Changes to the Lending and Repayment Dates of Funds.
2026-06-18
Nomura Micro Science Co., Ltd. reported earnings results for the full year ended March 31, 2026. For the full year, the company reported sales was JPY 56,245.86 million compared to JPY 96,359.95 million a year ago. Net income was JPY 3,818.17 million compared to JPY 10,199.64 million a year ago. Basic earnings per share from continuing operations was JPY 100.36 compared to JPY 270.75 a year ago. Diluted earnings per share from continuing operations was JPY 98.42 compared to JPY 263.64 a year ago.
2026-06-06
Nomura Micro Science Co., Ltd. provided dividend guidance for the second quarter-end of fiscal year ending March 31, 2027. For the period, the company expects dividend to be JPY 30.00 per share against JPY 20.00 per share paid a year ago.
2026-06-06
Nomura Micro Science Co., Ltd. provided year-end dividend guidance for the fiscal year ending March 31, 2027. For the period, the company expects dividend to be JPY 55.00 per share against JPY 61.00 per share a year ago.
2026-06-06
Nomura Micro Science Co., Ltd. provided consolidated earnings guidance for the six month ending September 30, 2026 and full year ending March 31, 2027. For the six month, the company expected net sales of JPY 34,500 million, operating profit of JPY 3,600 million, profit attributable to owners of parent of JPY 1,961 million and basic earnings per share of JPY 51.22. For the year, the company expected net sales of JPY 97,000 million, operating profit of JPY 16,000 million, profit attributable to owners of parent of JPY 11,100 million and basic earnings per share of JPY 289.90.
2026-05-20
Nomura Micro Science Co., Ltd., Board Meeting, May 20, 2026. Agenda: To consider the Notice regarding Dividends of Surplus.
2026-05-14
Nomura Micro Science Co., Ltd., Annual General Meeting, Jun 24, 2026.
2026-05-14
Nomura Micro Science Co., Ltd., 2026 Earnings Call, May 22, 2026
2026-05-09
Nomura Micro Science Co., Ltd. announced that they will report fiscal year 2026 results on May 14, 2026
2026-05-09
Nomura Micro Science Co., Ltd. announced that they will report Q1, 2027 results on Aug 07, 2026
2026-05-09
Nomura Micro Science Co., Ltd. announced that they will report Q2, 2027 results on Nov 13, 2026
2026-02-18
Nomura Micro Science Co., Ltd. reported earnings results for the nine months ended December 31, 2025. For the nine months, the company reported sales was JPY 41,046.95 million compared to JPY 31,855.2 million a year ago. Net income was JPY 2,865.85 million compared to JPY 2,066.32 million a year ago. Basic earnings per share from continuing operations was JPY 75.43 compared to JPY 54.91 a year ago. Diluted earnings per share from continuing operations was JPY 74.01 compared to JPY 53.47 a year ago.
2026-02-14
Nomura Micro Science Co., Ltd. provided consolidated earnings guidance for the year ending March 31, 2026. For the year ending March 31, 2026, the company expects net sales of JPY 60,000 million, operating profit of JPY 6,200 million and profit attributable to owners of parent of JPY 3,837 million or JPY 100.90 per basic share.
2026-02-13
Nomura Micro Science Co., Ltd. expected to report Fiscal Year 2026 results on May 15, 2026. This event was calculated by S&P Global (Created on February 13, 2026).
2026-02-13
Nomura Micro Science Co., Ltd., Board Meeting, Feb 13, 2026. Agenda: To consider changing the repayment due date of the borrowed funds; and to consider other business matters.
2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 | 2024Q4 | 2024Q3 | 2024Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|
Total Revenues | 55,184 | 53,044 | 56,245 | 105,552 | 103,510 | 101,134 | 96,360 | 43,579 | 54,508 | 67,883 |
Pretax Income Excl.Unusual Items | 3,404 | 5,186 | 5,628 | 14,422 | 15,400 | 13,637 | 13,349 | 5,188 | 4,638 | 9,220 |
Total Assets | 112,035 | 111,078 | 110,290 | 109,712 | 103,959 | 103,874 | 116,783 | 100,351 | 88,415 | 79,742 |
Total Liabilities | 73,771 | 72,537 | 70,439 | 71,056 | 67,138 | 68,924 | 79,769 | 71,018 | 60,726 | 51,048 |
Cash & Cash Equivalents | 9,900 | 8,473 | 10,425 | 13,663 | 15,089 | 18,890 | 16,540 | 11,642 | 11,682 | 15,488 |
Total Common Equity | 38,264 | 38,541 | 39,851 | 38,656 | 36,821 | 34,950 | 37,014 | 29,333 | 27,689 | 28,694 |
Book Value Per Share (BVPS) | 993.89 | 1,003.91 | 1,040.8 | 1,013.68 | 967.27 | 923.02 | 977.57 | 777.51 | 734.33 | 764.24 |
Net Change in Cash | -5,470 | -6,606 | 4,235 | 4,680 | -10,399 | |||||
Capital Expenditure | -1,384 | -1,378 | -808 | -2,104 | -2,009 |
On November 13, 2026, Nomura Micro Science shared its financial results for the third quarter of 2026, with revenues of 14.93B yen and net loss of -0.47B yen, reflecting a 16.7% uptick in revenue, with a shift from a profit per share in the same quarter last year to a loss per share in the current quarter.
Moreover, the EBITDA margin decreased significantly from 15.27% to 5.63% in the comparable quarter previous year. A decline in operating profitability can signify a problem with sales or a rise in operating expenses, which could be detrimental to the stock's performance in the future. It is important to note that the stock's dividend yield stands at approximately 4.1%, and it trades at 34.6x times current year's earnings, which is higher than the sector average (P/E 11.8x).